Panpan Hou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Panpan Hou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Macau University Of Science And Technology | Macau

Assist. Prof. Dr. Panpan Hou is a distinguished researcher in the field of Biomedical Engineering and Biophysics, with a prolific record of 375 documents, 541 citations, and an h-index of 16. After obtaining a B.S. in Biomedical Engineering and a Ph.D. in Biophysics from Huazhong University of Science and Technology, Dr. Hou completed postdoctoral training at Washington University in St. Louis before joining Macau University of Science and Technology as an Assistant Professor in 2021. Dr. Hou’s research focuses on ion channel physiology, voltage-sensor domain (VSD) mechanisms, and electro-mechanical coupling, elucidating complex molecular processes such as the VSD-pore coupling in KCNQ1 channels and identifying novel modulators with therapeutic potential. He has made significant contributions to drug screening, cardiovascular disease modeling, and electrophysiology, publishing high-impact work in journals including Nature Communications, PNAS, eLife, Circulation Research, and Scientific Reports. Dr. Hou has received multiple awards including the AHA Postdoctoral Fellowship, Best Poster Awards at international symposia, and the 2025 Best Research Output Award from Macau University of Science and Technology. Beyond research, he actively mentors students, serves on editorial boards, and contributes to national and international scientific societies. With a strong track record of innovation, mentorship, and high-impact publications, Dr. Hou exemplifies excellence in biomedical research and is poised to advance the understanding of ion channel physiology and therapeutic interventions.

Profiles : Scopus | Orcid | Google Scholar

Featured Publications

Zhong, L., Lin, X., Cheng, X., Wan, S., Hua, Y., Nan, W., Hu, B., Peng, X., Zhou, Z., Zhang, Q., Yang, H., Noé, F., Yan, Z., Jiang, D., Zhang, H., Liu, F., Xiao, C., Zhou, Z., Mou, Y., Yu, H., Ma, L., Huang, C., Wong, V. K. W., Chung, S. K., Shen, B., Jiang, Z.-H., Neher, E., Zhu, W., Zhang, J., & Hou, P. (2025). Secondary structure transitions and dual PIP2 binding define cardiac KCNQ1-KCNE1 channel gating. Cell Research.

Hou, P., Zhao, L., Zhong, L., Shi, J., Wang, H. Z., Gao, J., Liu, H., Zuckerman, J., Cohen, I. S., & Cui, J. (2024). The fully activated open state of KCNQ1 controls the cardiac “fight-or-flight” response. PNAS Nexus.

Liu, Y., Xu, X., Gao, J., Naffaa, M. M., Liang, H., Shi, J., Wang, H. Z., Yang, N.-D., Hou, P., & Zhao, W. (2022). Author correction: A PIP2 substitute mediates voltage sensor-pore coupling in KCNQ activation. Communications Biology.

Dou, A., Kang, P. W., Hou, P., Zaydman, M. A., Zheng, J., Jegla, T., & Cui, J. (2021). Principles of sensor-effector organization in six-transmembrane ion channels.

Lin, Y., Grinter, S. Z., Lu, Z., Xu, X., Wang, H. Z., Liang, H., Hou, P., Gao, J., Clausen, C., & Shi, J. (2021). Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects. Proceedings of the National Academy of Sciences.

Liu, Y., Xu, X., Gao, J., Naffaa, M. M., Liang, H., Shi, J., Wang, H. Z., Yang, N.-D., Hou, P., & Zhao, W. (2020). A PIP2 substitute mediates voltage sensor-pore coupling in KCNQ activation. Communications Biology.

Taylor, K. C., Kang, P. W., Hou, P., Yang, N.-D., Kuenze, G., Smith, J. A., Shi, J., Huang, H., McFarland White, K., & Peng, D. (2020). Structure and physiological function of the human KCNQ1 channel voltage sensor intermediate state. eLife.

Hou, P., Kang, P. W., Kongmeneck, A. D., Yang, N.-D., Liu, Y., Shi, J., Xu, X., McFarland White, K., Zaydman, M. A., Kasimova, M. A., Seebohm, M., Zhong, L., Zou, X., Tarek, M., & Cui, J. (2020). Two-stage electro–mechanical coupling of a KV channel in voltage-dependent activation. Nature Communications.

Zhu, W., Mazzanti, A., Voelker, T. L., Hou, P., Moreno, J. D., Angsutararux, P., Naegle, K. M., Priori, S. G., & Silva, J. R. (2019). Predicting patient response to the antiarrhythmic mexiletine based on genetic variation: Personalized medicine for long QT syndrome. Circulation Research.

Hou, P., Kang, P. W., Kongmeneck, A. D., Yang, N.-D., Liu, Y., Shi, J., Xu, X., McFarland White, K., Zaydman, M. A., Kasimova, M. A., Seebohm, M., Zhong, L., Zou, X., Tarek, M., & Cui, J. (2019). Two-stage electro-mechanical coupling of a KV channel in voltage-dependent activation.

Hou, P., Shi, J., McFarland White, K., Gao, Y., & Cui, J. (2019). ML277 specifically enhances the fully activated open state of KCNQ1 by modulating VSD-pore coupling. eLife.

Hou, P., Shi, J., McFarland White, K., Gao, Y., & Cui, J. (2019). ML277 specifically enhances pore opening of KCNQ1 with VSD at the activated state by modulating VSD-pore coupling.

Hou, P., Eldstrom, J., Shi, J., Zhong, L., McFarland, K., Gao, Y., Fedida, D., & Cui, J. (2017). Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening. Nature Communications.

Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Prof. Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Beijing Anzhen Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Yunlong Wang began his illustrious academic journey at the prestigious Peking University Health Science Center, where he earned his Doctor of Cardiology (M.D.). Driven by an unwavering passion for cardiac sciences, he later expanded his expertise internationally through visiting scholar roles at Asklepios St. Georg Hospital, University of Chicago Hospital, and the Hospital of the University of Pennsylvania , specializing in electrophysiology. These experiences provided a robust foundation for his future contributions to cardiac arrhythmia treatment.

Professional Endeavors

Prof. Wang has been a cornerstone of Beijing Anzhen Hospital, Capital Medical University since 2007. As the Chief Physician and Executive Director of the Arrhythmias Ward Three, he oversees the department’s advanced cardiac electrophysiology operations. With unmatched skill, he performs over 1400 tachyarrhythmia radiofrequency ablation procedures annually. In addition to his clinical duties, he is a respected doctoral supervisor, educator for undergraduate medical students, and a key figure in national cardiovascular intervention training programs authorized by China’s National Health Commission.

Contributions and Research Focus

Prof. Wang’s clinical expertise centers on the diagnosis and radiofrequency ablation treatment of complex tachyarrhythmias such as persistent atrial fibrillation, premature ventricular contractions, and ventricular tachycardia. His research portfolio includes pivotal studies in both basic and clinical science. His fundamental research has been supported by the National Natural Science Foundation of China, examining the roles of CRT and the HIF-1α-Nkx2.5 axis in cardiac remodeling and ion channel regulation. His clinical investigations have significantly advanced understanding and treatment of arrhythmias, with more than ten SCI-indexed papers published as lead or corresponding author in the last five years.

Accolades and Recognition

Prof. Wang is a prominent member of several key professional bodies, including the National Committee of the Chinese Society of Biomedical Engineering (Electrocardiogram Technology Branch), and serves on the youth committees of the Heart Rhythm Branch and Beijing Medical Association. His scholarly contributions have been featured in high-impact journals such as Heart Rhythm, Europace, and J Cardiovasc Electrophysiol, affirming his stature in the field of cardiac electrophysiology.

Impact and Influence

Prof. Wang's leadership in arrhythmia treatment has redefined procedural benchmarks across China. By educating the next generation of cardiologists and shaping national training protocols, his influence permeates both clinical and academic spheres. His pioneering research in radiofrequency ablation and cardiac electrophysiology continues to inform best practices globally.

Legacy and Future Contributions

Prof. Wang’s legacy is built on a blend of surgical excellence, scientific inquiry, and educational mentorship. As cardiac electrophysiology continues to evolve, his ongoing research into molecular pathways and ablation techniques is poised to unlock new treatment paradigms. With a steadfast commitment to innovation and clinical precision, he remains a vital contributor to the future of cardiovascular medicine in China and beyond.

 

Publications


The mC2HEST Score for Incident Atrial Fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)

  • Authors: Yanguang Li, Qiaoyuan Li, Lili Wang, Tao Zhang, Hai Gao, Daniele Pastori, Zhuo Liang, Gregory Y.H. Lip, Yunlong Wang

  • Journal: JACC: Advances

  • Year: 2025


Left atrial size and echocardiographic diastolic parameters as predictors of incident atrial fibrillation in older hospitalized patients

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Aging Clinical and Experimental Research

  • Year: 2025


Atrial fibrillation phenotypes identified through cluster analysis in the CABANA study

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: International Journal of Cardiology

  • Year: 2025


Prompt Identification of the Location of Gap Conduction in the Mitral Isthmus Following Vein of Marshall Ethanol Infusion and Endocardial Ablation

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Circulation: Arrhythmia and Electrophysiology

  • Year: 2025


Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy

  • Authors: Ying Xie, Qiaoyuan Li, Xiyun Bian, Yan Yin, Zhuo Liang, Xu Liu, Tao Zhang, Xiaozhi Liu, Xin Quan, Yunlong Wang

  • Journal: Clinical and Translational Medicine (Wiley)

  • Year: 2025